Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 3/2020

01-06-2020 | Pituitary Adenoma | Review

Diagnosis and Management of pituitary disease with focus on the role of Magnetic Resonance Imaging

Authors: Amit Mahajan, Richard A. Bronen, Ali Y. Mian, Sacit Bulent Omay, Dennis D. Spencer, Silvio E. Inzucchi

Published in: Endocrine | Issue 3/2020

Login to get access

Abstract

Magnetic resonance (MR) imaging is an essential tool in the diagnosis and management of pituitary diseases, indispensable for making correct treatment decisions. Successful management and follow-up of pituitary pathology requires an understanding of the MR appearance of normal and abnormal structures in the sellar region. This review will describe the MR appearance of the normal and abnormal pituitary gland and proposes an algorithm for the management strategy of some of the most common abnormalities in or around the sella.
Literature
1.
R.B. Dietrich, L.E. Lis, F.S. Greensite, D. Pitt, Normal MR appearance of the pituitary gland in the first 2 years of life. Am. J. Neuroradiol. 16, 1413–1419 (1995)PubMed
2.
B.S. Brooks, T. el Gammal, J.D. Allison, W.H. Hoffman, Frequency and variation of the posterior pituitary bright signal on MR images. Am. J. Neuroradiol. 10, 943–948 (1989)PubMed
3.
R.R. Lleva, S.E. Inzucchi, Diagnosis and management of pituitary adenomas. Curr. Opin. Oncol. 23, 53–60 (2011)PubMed
4.
M.E. Molitch, Diagnosis and treatment of pituitary adenomas: a review. Jama 317, 516–524 (2017)PubMed
5.
M.E. Molitch, Pituitary incidentalomas. Best. Pract. Res. Clin. Endocrinol. Metab. 23, 667–675 (2009)PubMed
6.
W.A. Hall, M.G. Luciano, J.L. Doppman, N.J. Patronas, E.H. Oldfield, Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann. Intern Med 120, 817–820 (1994)PubMed
7.
C.C. Chen, B.S. Carter, R. Wang, K.S. Patel, C. Hess, M.E. Bodach et al. Congress of neurological surgeons systematic review and evidence-based guideline on preoperative imaging assessment of patients with suspected nonfunctioning pituitary adenomas. Neurosurgery 79, E524–E526 (2016)PubMed
8.
A. Hagiwara, Y. Inoue, K. Wakasa, T. Haba, T. Tashiro, T. Miyamoto, Comparison of growth hormone-producing and non-growth hormone-producing pituitary adenomas: imaging characteristics and pathologic correlation. Radiology 228, 533–538 (2003)PubMed
9.
J. Gsponer, N. De Tribolet, J.P. Deruaz, R. Janzer, A. Uske, R.O. Mirimanoff et al. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients. Med. (Baltim.) 78, 236–269 (1999)
10.
M.M. Fernandez-Balsells, M.H. Murad, A. Barwise, J.F. Gallegos-Orozco, A. Paul, M.A. Lane et al. Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis. J. Clin. Endocrinol. Metab. 96, 905–912 (2011)PubMed
11.
K. Arita, A. Tominaga, K. Sugiyama, K. Eguchi, K. Iida, M. Sumida et al. Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination. J. Neurosurg. 104, 884–891 (2006)PubMed
12.
O.M. Dekkers, S. Hammer, R.J. de Keizer, F. Roelfsema, P.J. Schutte, J.W. Smit et al. The natural course of non-functioning pituitary macroadenomas. Eur. J. Endocrinol. 156, 217–224 (2007)PubMed
13.
J.W. Lucas, M.E. Bodach, L.M. Tumialan, N.M. Oyesiku, C.G. Patil, Z. Litvack et al. Congress of neurological surgeons systematic review and evidence-based guideline on primary management of patients with nonfunctioning pituitary adenomas. Neurosurgery 79, E533–E535 (2016)PubMed
14.
P.J. Yeh, J.W. Chen, Pituitary tumors: surgical and medical management. Surg. Oncol. 6, 67–92 (1997)PubMed
15.
T. Mancini, F.F. Casanueva, A. Giustina, Hyperprolactinemia and prolactinomas. Endocrinol. Metab. Clin. North Am. 37, 67–99 (2008). viiiPubMed
16.
F.F. Casanueva, M.E. Molitch, J.A. Schlechte, R. Abs, V. Bonert, M.D. Bronstein et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin. Endocrinol. (Oxf.) 65, 265–273 (2006)
17.
M.E. Molitch, Medical treatment of prolactinomas. Endocrinol. Metab. Clin. North Am. 28, 143–169 (1999). viiPubMed
18.
A. Klibanski, Clinical practice. Prolactinomas. N. Engl. J. Med 362, 1219–1226 (2010)PubMed
19.
M. Buchfelder, S. Schlaffer, Imaging of pituitary pathology. Handb. Clin. Neurol. 124, 151–166 (2014)PubMed
20.
J.F. Bonneville, F. Bonneville, F. Cattin, Magnetic resonance imaging of pituitary adenomas. Eur. Radio. 15, 543–548 (2005)
21.
L. Katznelson, E.R. Laws Jr, S. Melmed, M.E. Molitch, M.H. Murad, A. Utz et al. Acromegaly: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99, 3933–3951 (2014)PubMed
22.
A. Mestron, S.M. Webb, R. Astorga, P. Benito, M. Catala, S. Gaztambide et al. Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur. J. Endocrinol. 151, 439–446 (2004)PubMed
23.
J.L. Shin, S.L. Asa, L.J. Woodhouse, H.S. Smyth, S. Ezzat, Cystic lesions of the pituitary: clinicopathological features distinguishing craniopharyngioma, Rathke’s cleft cyst, and arachnoid cyst. J. Clin. Endocrinol. Metab. 84, 3972–3982 (1999)PubMed
24.
A. Teramoto, K. Hirakawa, N. Sanno, Y. Osamura, Incidental pituitary lesions in 1,000 unselected autopsy specimens. Radiology 193, 161–164 (1994)PubMed
25.
S.Q. Wolfe, R.C. Heros, Editorial. J. Neurosurg. 112, 1322–1323 (2010)PubMed
26.
C.J. Aho, C. Liu, V. Zelman, W.T. Couldwell, M.H. Weiss, Surgical outcomes in 118 patients with Rathke cleft cysts. J. Neurosurg. 102, 189–193 (2005)PubMed
27.
L. Cervoni, M. Artico, M. Salvati, S. Carloia, Rathke’s cleft cyst: a clinical and radiographic review. Ital. J. Neurol. Sci. 18, 37–40 (1997)PubMed
28.
S. Chotai, Y. Liu, J. Pan, S. Qi, Characteristics of Rathke’s cleft cyst based on cyst location with a primary focus on recurrence after resection. J. Neurosurg. 122, 1380–1389 (2015)PubMed
29.
S.M. Tavangar, B. Larijani, A. Mahta, S.M. Hosseini, M. Mehrazine, F. Bandarian, Craniopharyngioma: a clinicopathological study of 141 cases. Endocr. Pathol. 15, 339–344 (2004). WinterPubMed
30.
T.B. Crotty, B.W. Scheithauer, W.F. Young Jr, D.H. Davis, E.G. Shaw, G.M. Miller et al. Papillary craniopharyngioma: a clinicopathological study of 48 cases. J. Neurosurg. 83, 206–214 (1995)PubMed
31.
N. Karavitaki, C. Brufani, J.T. Warner, C.B. Adams, P. Richards, O. Ansorge et al. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin. Endocrinol. (Oxf.) 62, 397–409 (2005)
32.
R. Sorva, O. Heiskanen, Craniopharyngioma in Finland. Acta Neurochirurgica 81, 85–89 (1986)PubMed
33.
M. Güdük, M. HamitAytar, A. Sav, Z. Berkman, Intrasellar arachnoid cyst: a case report and review of the literature. Int. J. Surg. case Rep. 23, 105–108 (2016)PubMedPubMedCentral
34.
F. Gudinchet, F. Brunelle, M.O. Barth, V. Taviere, R. Brauner, R. Rappaport et al. MR imaging of the posterior hypophysis in children. AJR Am. J. Roentgenol. 153, 351–354 (1989)PubMed
35.
A.F. Turcu, B.J. Erickson, E. Lin, S. Guadalix, K. Schwartz, B.W. Scheithauer et al. Pituitary stalk lesions: the Mayo Clinic experience. J. Clin. Endocrinol. Metab. 98, 1812–1818 (2013)PubMed
36.
B.E. Hamilton, K.L. Salzman, A.G. Osborn, Anatomic and pathologic spectrum of pituitary infundibulum lesions. AJR Am. J. Roentgenol. 188, W223–W232 (2007)PubMed
37.
M.E. Molitch, M.P. Gillam, Lymphocytic hypophysitis. Horm. Res 68, 145–150 (2007)PubMed
38.
P. Caturegli, C. Newschaffer, A. Olivi, M.G. Pomper, P.C. Burger, N.R. Rose, Autoimmune hypophysitis. Endocr. Rev. 26, 599–614 (2005)PubMed
39.
H. Bando, G. Iguchi, H. Fukuoka, M. Taniguchi, M. Yamamoto, R. Matsumoto et al. The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and/or central diabetes insipidus and review of the literature. Eur. J. Endocrinol. 170, 161–172 (2014)PubMed
40.
J. Shikuma, K. Kan, R. Ito, K. Hara, H. Sakai, T. Miwa et al. Critical review of IgG4-related hypophysitis. Pituitary 20, 282–291 (2017)PubMed
41.
M.N. Joshi, B.C. Whitelaw, M.T. Palomar, Y. Wu, P.V. Carroll, Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review. Clin. Endocrinol. (Oxf.) 85, 331–339 (2016)
42.
Y. Okano, T. Satoh, K. Horiguchi, M. Toyoda, A. Osaki, S. Matsumoto et al. Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma. Endocr. J. 63, 905–912 (2016)PubMed
43.
C. Briet, S. Salenave, J.-F. Bonneville, E.R. Laws, P. Chanson, Pituitary apoplexy. Endocr. Rev. 36, 622–645 (2015)PubMed
44.
A. Raappana, J. Koivukangas, T. Ebeling, T. Pirila, Incidence of pituitary adenomas in Northern Finland in 1992–2007. J. Clin. Endocrinol. Metab. 95, 4268–4275 (2010)PubMed
45.
N. Kurihara, S. Takahashi, S. Higano, H. Ikeda, S. Mugikura, L.N. Singh et al. Hemorrhage in pituitary adenoma: correlation of MR imaging with operative findings. Eur. Radiol. 8, 971–976 (1998)PubMed
Metadata
Title
Diagnosis and Management of pituitary disease with focus on the role of Magnetic Resonance Imaging
Authors
Amit Mahajan
Richard A. Bronen
Ali Y. Mian
Sacit Bulent Omay
Dennis D. Spencer
Silvio E. Inzucchi
Publication date
01-06-2020
Publisher
Springer US
Published in
Endocrine / Issue 3/2020
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-020-02242-3

Other articles of this Issue 3/2020

Endocrine 3/2020 Go to the issue

Original Article

Endocrine surgery during COVID-19 pandemic: do we need an update of indications in Italy?

Original Article

Targeted next generation sequencing of nine osteoporosis-related genes in the Wnt signaling pathway among Chinese postmenopausal women

Original Article

Androgenetic alopecia: effects of oral finasteride on hormone profile, reproduction and sexual function

Original Article

Atrophy patterns of hippocampal subfields in T2DM patients with cognitive impairment

Original Article

Approved LXR agonists exert unspecific effects on pancreatic β-cell function

Original Article

Mild TPO deficiency characterized by progressive goiter and normal serum TSH level
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits